BioPharmSignal logoBioPharmSignal

Biotech News

Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference

Wave Life Sciences (WVE)Wave Life SciencesConference / presentation

Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in the “RNA Medicines: Next-Generation RNA Therapeutics” panel at Chardan’s 10 th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026 at 9:45 a.m. ET.

Related news

WVEWave Life Sciences2026-09-03 20:05 EST

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference

WVEWave Life Sciences2026-05-13 20:05 EST

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

KZRKezar Life Sciences2020-02-26 21:01 EST

Kezar Life Sciences to Present at Cowen and Company’s 40th Annual Healthcare Conference

KZRKezar Life Sciences2019-11-27 21:05 EST

Kezar Life Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference

SLSSELLAS Life Sciences Group, Inc.2026-09-02 12:30 EST

SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer

RGENRepligen2026-08-26 11:30 EST

Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference

RGENRepligen2026-05-07 11:30 EST

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

TECHBio-Techne2026-05-04 11:00 EST

Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

TECHBio-Techne2025-12-23 12:00 EST

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

TXG10x Genomics2021-08-31 20:05 EST

10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

View all latest news

Wave Life Sciences

RNA Medicines Platform Company Wave Life Sciences is a clinical-stage biotechnology company developing RNA medicines across both rare and common diseases. Its PRISM platform combines RNA-targeting modalities, chemistry innovation, and human genetics to design medicines that can address disease biology through RNAi and RNA...

Recent company news

WVEWave Life Sciences2026-10-20 12:30 EST

Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026

WVEWave Life Sciences2026-10-19 12:30 EST

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

WVEWave Life Sciences2026-10-13 12:30 EST

Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference

WVEWave Life Sciences2026-10-01 11:30 EST

Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD

WVEWave Life Sciences2026-09-30 11:30 EST

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Stock data

Close
3.22 USD
Market cap
1.09B USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States